Поисковый запрос: (<.>S=ГИДРОКСИДОФАМИН<.>) |
Общее количество найденных документов : 784
Показаны документы с 1 по 20
|
|
1.
| 'Priming' enhances the relationship of striatal L-DOPA concentration to behavior // NeuroReport, 1994. Vol. 5, N 13.-С.1665-1669
|
2.
| 'альфа'-Methyl-ptyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation // Brain Res., 1990. Vol. 515, N 1-2.-С.269-276
|
3.
| 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA // J. Neurochem., 2008. Vol. 104, N 6.-С.1599-1612
|
4.
| 6-hydroxydopamine lesions of the locus coeruleus induce a paradoxical increase in growth hormone secretion in male rats // J. Neuroendocrinol, 1992. Vol. 4, N 1.-С.9-14
|
5.
| 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence cocaine-induced place conditioning // Behav. Brain. Res., 1992. Vol. 49, N 2.-С.225-230
|
6.
| 6-OHDA lesions in the nucleus accumbens do not affect latent inhibition // Behav. Pharmacol., 1994. Vol. 5, Suppl. N1.-С.121
|
7.
| 7,8-Dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cell death through modulating PI3K/Akt and JNK pathways // Neurosci. Lett., 2014. Vol. 581.-С.85-88
|
8.
| A 6-hydroxydopamine-induced selective parkinsonian rat model // Brain Res., 1989. Vol. 494, N 2.-С.285-293
|
9.
| A continuous striatal infusion of 6-hydroxydopamine produces a terminal axotomy and delayed behavioral effects // Brain Res., 1996. Vol. 709, N 2.-С.275-284
|
10.
| A continuous striatal infusion of 6-hydroxydopamine produces a terminal axotomy and delayed behavioral effects // Brain Res., 1996. Vol. 709, N 2.-С.275-284
|
11.
| A dose related response of 6-OHDA on chicken spectral sensitivity and oscillatory potentials of recording electroretinograms // Chin. Med. J., 1996. Vol. 109, N 10.-С.762-770
|
12.
| A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease // NeuroReport, 1997. Vol. 8, N 3.-С.669-672
|
13.
| A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease // NeuroReport, 1997. Vol. 8, N 3.-С.669-672
|
14.
| A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-'каппа'B and the PKC'альфа'/PI3-K/Akt pathways // Neurochem. Int., 2014. Vol. 78.-С.76-85
|
15.
| A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease // J. Pharmacol. and Exp. Ther., 2004. Vol. 310, N 2.-С.828-835
|
16.
| A rat model of early phases of Parkinson's disease: An innovative tool to investigate the role of environmental factors in the onset and progression of neurodegenerative disorders // Congr. ISTISAN, 2009, N C12.-С.121
|
17.
| A single injection of a biodegradable microsphere formulation of the ACTH-(4-9) analogue ORG 2766 accelerates functional recovery after brain damage // J. Pharm. and Pharmacol., 1990. Vol. 42, N 7.-С.508-510
|
18.
| A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydrodopamine neurotoxicity // Neuroscience, 2006. Vol. 143, N 1.-С.1-6
|
19.
| Abercrombie Adaptation of catecholaminergic systems to partial injury // J. Neurosci. Meth., 1989. Vol. 29, N 3.-С.277
|
20.
| Action sites of rotation and unit firing induced by l-stepholidine and DA agonists in basal ganglia of 6-OHDA-lesioned rats // Acta Pharmacol. Sin., 1999. Vol. 20, N 11.-С.979-986
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"